Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality

Psychosom Med. 2007 Jun;69(5):396-401. doi: 10.1097/PSY.0b013e31806d040b.

Abstract

Objective: To examine the relationships among the variable number of tandem repeats in the monoamine oxidase-A linked polymorphic region allelic variation (MAOA-uVNTR) and the symptoms of depression and sleep quality. The monoamine oxidase-A (MAOA) gene, which plays a vital role in degradation of neurotransmitters such as serotonin, norepinephrine, and dopamine, contains a polymorphism in its promoter region (MAOA-uVNTR) that affects transcriptional efficiency. MAOA-uVNTR genotype has been associated with both psychological and physical measures.

Methods: The sample consisted of 74 males enrolled in a case/control study of caregivers for relatives with dementia. Age- and race-adjusted linear regression models were used to examine the association between low versus high MAOA-uVNTR activity alleles, symptoms of depression (Center for Epidemiological Studies of Depression), and sleep quality ratings (Pittsburgh Sleep Quality Index).

Results: MAOA-uVNTR alleles associated with less transcriptional activity were related to increased symptoms of depression (p < .04; Cohen's d = 0.52) and poorer sleep quality (p < .04; Cohen's d = 0.31).

Conclusions: Individuals with less active MAOA-uVNTR alleles may be at increased risk for depressive symptoms and poor sleep.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Case-Control Studies
  • Depression / genetics*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Monoamine Oxidase / genetics*
  • Polymorphism, Genetic*
  • Promoter Regions, Genetic
  • Risk
  • Sleep Wake Disorders / genetics*
  • Tandem Repeat Sequences

Substances

  • Monoamine Oxidase